Literature DB >> 8807068

Effect of combination therapy with ciprofloxacin and clarithromycin on theophylline pharmacokinetics in healthy volunteers.

J G Gillum1, D S Israel, R B Scott, M W Climo, R E Polk.   

Abstract

Five adults completed this four-way randomized crossover study to compare the effects of oral treatment with ciprofloxacin, clarithromycin, and a combination of the two drugs on theophylline pharmacokinetics. The area under the concentration-time curve for theophylline during combination therapy was not different from that for ciprofloxacin alone. Beta error may explain this finding, but any real effect from combination treatment appears to be clinically unimportant.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8807068      PMCID: PMC163401     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Meta-analysis of quinolone-theophylline interactions.

Authors:  M Parent; M LeBel
Journal:  DICP       Date:  1991-02

2.  Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1.

Authors:  L Gu; F J Gonzalez; W Kalow; B K Tang
Journal:  Pharmacogenetics       Date:  1992-04

Review 3.  The theophylline-erythromycin interaction.

Authors:  M J Rieder; M Spino
Journal:  J Asthma       Date:  1988       Impact factor: 2.515

4.  Revised FDA labeling guideline for theophylline oral dosage forms.

Authors:  L Hendeles; J Jenkins; R Temple
Journal:  Pharmacotherapy       Date:  1995 Jul-Aug       Impact factor: 4.705

5.  Theophylline, ciprofloxacin, erythromycin: a potentially harmful regimen.

Authors:  R P Rockwood; L S Embardo
Journal:  Ann Pharmacother       Date:  1993-05       Impact factor: 3.154

Review 6.  Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.

Authors:  U Tröger; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

7.  Metabolism of theophylline by cDNA-expressed human cytochromes P-450.

Authors:  H R Ha; J Chen; A U Freiburghaus; F Follath
Journal:  Br J Clin Pharmacol       Date:  1995-03       Impact factor: 4.335

8.  Characterization of human liver cytochromes P-450 involved in theophylline metabolism.

Authors:  M A Sarkar; C Hunt; P S Guzelian; H T Karnes
Journal:  Drug Metab Dispos       Date:  1992 Jan-Feb       Impact factor: 3.922

Review 9.  Pharmacokinetic drug interactions of macrolides.

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Clin Pharmacokinet       Date:  1992-08       Impact factor: 6.447

10.  Inhibitory potency of quinolone antibacterial agents against cytochrome P450IA2 activity in vivo and in vitro.

Authors:  U Fuhr; E M Anders; G Mahr; F Sörgel; A H Staib
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

  10 in total
  6 in total

Review 1.  Clinical pharmacokinetics of clarithromycin.

Authors:  K A Rodvold
Journal:  Clin Pharmacokinet       Date:  1999-11       Impact factor: 6.447

Review 2.  Importance of multi-p450 inhibition in drug-drug interactions: evaluation of incidence, inhibition magnitude, and prediction from in vitro data.

Authors:  Nina Isoherranen; Justin D Lutz; Sophie P Chung; Houda Hachad; Rene H Levy; Isabelle Ragueneau-Majlessi
Journal:  Chem Res Toxicol       Date:  2012-09-27       Impact factor: 3.739

Review 3.  Choosing the right macrolide antibiotic. A guide to selection.

Authors:  L Charles; J Segreti
Journal:  Drugs       Date:  1997-03       Impact factor: 9.546

Review 4.  Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions.

Authors:  F Pea; M Furlanut
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 5.577

Review 5.  Differential pharmacokinetics of theophylline in elderly patients.

Authors:  Akihiro Ohnishi; Motokazu Kato; Jun Kojima; Hideki Ushiama; Maki Yoneko; Hiroyuki Kawai
Journal:  Drugs Aging       Date:  2003       Impact factor: 4.271

6.  Pharmacokinetic drug interactions of antimicrobial drugs: a systematic review on oxazolidinones, rifamycines, macrolides, fluoroquinolones, and Beta-lactams.

Authors:  Mathieu S Bolhuis; Prashant N Panday; Arianna D Pranger; Jos G W Kosterink; Jan-Willem C Alffenaar
Journal:  Pharmaceutics       Date:  2011-11-18       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.